Product Description

Product Overview: The Blueprint for Targeted Anabolism Engineered with state-of-the-art Swiss precision, ACP-105 is a highly advanced, synthetic selective androgen receptor modulator (SARM). It was meticulously developed to deliver significant, measurable anabolic benefits while strictly minimizing the side-effect profile associated with traditional therapies. By exhibiting an extraordinarily high affinity for androgen receptors specifically located within skeletal muscle and bone tissue, ACP-105 completely bypasses the systemic activation of other hormonal pathways—such as those affecting the prostate.

Today, it stands as a premier, cutting-edge research tool utilized globally for protocols involving sarcopenia, osteoporosis, and accelerated musculoskeletal rehabilitation.

Mechanism of Action: Flawless Biological Engineering Upon selectively binding to precise androgen receptors, ACP-105 acts as a biological catalyst, instantly initiating the gene transcription responsible for rapid protein synthesis, deep cellular regeneration, and fortified bone mineralization. Crucially, this advanced compound does not interact with aromatase enzymes, entirely preventing estrogen conversion and ensuring a “dry,” high-quality tissue response. This unparalleled specificity allows researchers to study profound musculoskeletal enhancement without disrupting the body’s general endocrine regulation.

Comparative Analysis: The Agile Optimizer To fully appreciate its specialized role, ACP-105 is best understood in comparison to other compounds:

• vs. Ostarine (MK-2866): While sharing a similarly excellent safety profile and baseline anabolic potential, ACP-105 is celebrated for offering a noticeably faster onset of action. Both are ideal for pristine muscle preservation, but ACP-105 is heavily preferred for shorter, efficient protocols requiring moderate but highly distinct results.

• vs. Ligandrol (LGD-4033): Ligandrol provides more aggressive mass building but carries a significantly higher risk of hormonal suppression. ACP-105 serves as the refined alternative, delivering a milder anabolic effect with vastly less disruption to the natural hormonal axis, making it strictly superior for recovery-focused research.

• vs. S23: Unlike S23, which is aggressively potent and highly suppressive (often mandating TRT support), ACP-105 remains a “gentle” yet effective compound, perfectly suited for studies where absolute minimal systemic risk is a priority.

Precision Administration & Protocol Guidelines To ensure safety and maximize the regenerative properties of this compound, precise adherence to the dosing protocol is essential.

Recommended Protocol:

• Standard Dosage: 5 units administered once daily.

• Cycle Duration: A disciplined cycle of 4 to 6 weeks, mandatorily followed by a 2 to 4-week washout (recovery) period to ensure systemic balance.

Pen Specifications & Delivery:

• Total Capacity: Each highly concentrated 1.5ml precision pen contains a total of 150 units.

• Concentration Ratio: 1 unit is precisely equivalent to 233.33 mcg of active compound (optimizing the 35mg total yield).

Safety Profile & Tolerability ACP-105 is highly regarded for its excellent tolerability and smooth biological integration. However, researchers must note that potential, temporary suppression of endogenous testosterone and variable individual sensitivity may occur. As long-term systemic safety data remains limited, absolute adherence to the recommended cycle durations and recovery guidelines is critical.

The PEPTEXPERT Pharma Guarantee When you secure ACP-105 from PEPTEXPERT Pharma, you are investing in uncompromised biological purity. Synthesized under the most rigorous, Swiss-grade quality control standards, our specialized compounds guarantee a pristine purity level of >99%, delivering the exact, research-grade precision your protocols demand.